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Iterative type II polyketide synthases, cyclases and ketoreductases 
exhibit context-dependent behavior in the biosynthesis of linear 
and angular decapolyketides 
Guido Meurer I*, Martin Gerlitzl, Evelyn Wendt-Pienkowskil, Leo C Vining*, 
Jib-gen Rohr3 and C Richard Hutchinson114 
Background: Iterative type II polyketide synthases (PKSs) produce polyketide 
chains of variable but defined length from a specific starter unit and a number of 
extender units. They also specify the initial regiospecific folding and cyclization 
pattern of nascent polyketides either through the action of a cyclase (CYC) 
subunit or through the combined action of site-specific ketoreductase (KR) and 
CYC subunits. Additional CYCs and other modifications may be necessary to 
produce linear aromatic polyketides. The principles of the assembly of the linear 
aromatic polyketides, several of which are medically important, are well 
understood, but it is not clear whether the assembly of the angular aromatic 
(angucyclic) polyketides follows the same rules. 
Results: We performed an in viva evaluation of the subunits of the PKS 
responsible for the production of the angucyclic polyketide jadomycin (jad), in 
comparison with their counterparts from the daunorubicin (dps) and 
tetracenomycin (tcm) PKSs which produce linear aromatic polyketides. No matter 
which minimal PKS was used to produce the initial polyketide chain, the JadD and 
DpsF CYCs produced the same two polyketides, in the same ratio; neither 
product was angularly fused. The set ofjadABCED PKS plus putativejadl CYC 
genes behaved similarly. Furthermore, no angular polyketides were isolated when 
the entire set of jad PKS enzymes and Jadl or the jad minimal PKS, Jadl and the 
TcmN CYC were present. The DpsE KR was able to reduce decaketides but not 
octaketides; in contrast, the KRs from the jad PKS (JadE) or the actinorhodin PKS 
(Actlll) could reduce octaketide chains, giving three distinct products. 
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Conclusions: It appears that the biosynthesis of angucyclic polyketides cannot 
be simply accomplished by expressing the known PKS subunits from artificial 
gene cassettes under the control of a non-native promoter. The characteristic 
structure of the angucycline ring system may arise from a kinked precursor during 
later cyclization reactions involving additional, but so far unknown, components of 
the extended decaketide PKS. Our results also suggest that some KRs have a 
minimal chain length requirement and that CYC enzymes may act aberrantly as 
first-ring aromatases that are unable to perform all of the sequential cyclization 
steps. Both of these characteristics may limit the widespread application of CYC 
or KR enzymes in the synthesis of novel polyketides. 
Introduction 
Polyketides, a large and structurally diverse family of phar- 
maceutically important natural products, are produced by 
polyketide synthase (PKS) complexes through a specialized 
variation of fatty acid biosynthesis. Strong sequence and 
mechanistic similarities among many fatty acid and poly- 
ketide synthase enzymes led to PKSs being classified into 
type I and type II PKS systems, following the fatty acid 
synthase (FAS) classification system. Bacterial type I PKSs 
are usually large multifunctional enzyme complexes that 
process each of the initial or intermediate condensation 
products through ketoreduction, ketoreduction and dehy- 
dration, or ketoreduction, dehydration and enoyl reduction 
to produce highly reduced compounds from acetate, propi- 
onate and butyrate residues. In contrast, type II PKS com- 
plexes normally consist of three to seven monofunctional or 
bifunctional proteins in which none of the intermediate 
condensation products is subjected to processing until the 
full length polyketide chain is synthesized. Subsequent 
cyclizations and other modifications of the nascent polyke- 
tide introduce additional structural variability and typically 
yield aromatic compounds. 
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Figure 1 
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Polyketide synthase, ketoreductase and cyclase genes from the genes are further described in the text, except for those of the fun/-/ 
Streptomyces gene clusters governing the biosynthesis of and dnrG oxygenase genes, and the putative dpsC ketosynthase, 
tetracenomycin (tcm) C, actinorhodin (act), daunorubicin (dps or dnr) dpsD acyltransferase, dpsH cyclase and biotin carboxy carrier protein 
and jadomycin (iad) B. The organization of each set of genes is (BCCP) genes); orf, open reading frame; // indicates that the 
shown by wedges that are oriented in the direction of transcription adjacent dpsG and dpsH genes are located several kilobases from 
and the size of each is proportional to the size of the protein product. the other dps genes; kb, kilobase; the number 3 in 1 and * in 2-4 
The role of individual genes is indicated by a color corresponding to indicate the positions not reduced (3) or reduced (*) by the KR 
the function specified in the key at the bottom (the functions of these enzyme in each pathway. 
Iterative polyketide synthases that form aromatic com- Two groups of initial polyketide cyclases (CYCs) have 
pounds have become the subject of considerable interest been identified so far. One group regiospecifically folds 
over the last few years, not least because the common unreduced polyketides of various chain length at the C-11 
enzymatic mechanisms and the high degree of conserva- position, directing the first cyclization to take place 
tion that exists among type II PKS gene clusters (summa- between C-9 and C-14 and also influences the formation of 
rized in Figure 1 [l]) make them amenable to use for the second and third ring [8-lo]. A typical member of this 
generating novel polyketides through genetic engineering. group is the bifunctional TcmN CYC/O-methyltransferase 
Towards this end, many aromatic PKS recombinant gene involved in the biosynthesis of tetracenomycin C (com- 
cassettes have been constructed and tested to identify the pound 1, Figure 1) [ll]. The second and larger group, most 
proteins that are involved in determining chain length, the often represented by the ActVII enzyme involved in the 
degree and regiospecificity of ketoreduction, and the biosynthesis of actinorhodin (compound 2, Figure 1) [IZ], 
regiospecificity of cyclizations and aromatizations [Z-10]. It seems to promote only the regiospecific first-ring closure 
has been shown that chain length determination is an and subsequent aromatization of C-9 ketoreduced polyke- 
inherent property of the so-called ‘minimal PKS’, which tides in hybrid PKS systems [5,13]. Consequently, the 
contains the P-ketoacyl synthase subunits KS, and KS@ ActVII enzyme has been named an aromatase (ARO) [13]. 
(KSs was previously known as chain length determination (Some ActVII homologs can do more than just form and 
factor (CLF), but in fact both KS, and KSB affect chain aromatize a single six-membered ring, however, and 
length) and an acyl carrier protein (ACP; Figure 1) [6]. AR0 is an inappropriate designation for these enzymes.) 
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Members of the AR0 group of enzymes may exhibit an 
upper chain length limit, as was shown for ActVII [2,6] and 
the frenolicin (Fren) AR0 [14], and more than one CYC 
may be necessary for the defined closure of additional aro- 
matic rings to form linear tricyclic or tetracyclic compounds 
[14]. Recently, a set of predictive design rules for the gen- 
eration of aromatic polyketides was proposed on the basis 
of these studies and tested through the engineered biosyn- 
thesis of three novel products [14,15]. Here, we test these 
design rules further by concentrating on ketoreductases 
(KRs) and CYCs that promote the biosynthesis of reduced 
decaketides, especially those that produce the group of 
angucyclic polyketides (angucyclines) [ 161 represented by 
jadomycin (jad) B (compound 4, Figure 1) [17]. 
Results and discussion 
The design rules for the biosynthesis of reduced aromatic 
polyketides [ 141 are based primarily on results obtained by 
co-expressing a variety of minimal PKS gene sets contain- 
ing only the KS,, KS, and ACP genes with just a single 
KR gene (a&II), one of three AR0 genes (actvI1, fren 
AR0 or grisezlsin (gtir) ARO, depending on the expected 
chain length of the polyketide produced by the minimal 
PKS) and in some cases the a&V CYC gene [13] as well. 
Because all of these PKS genes come from well-known 
systems that produce linear aromatic polyketides, it was 
unclear whether angucycline-producing PKS systems [ 161 
would follow these same rules. 
We therefore set out to examine the behavior of functional 
subunits of an angucycline PKS, choosing the PKS that 
forms the carbon skeleton of jadomycin B (compound 4, 
Figure 1) [l&19]. The enzyme complex we studied con- 
sists of the putative minimal PKS (JadA, JadB and an ACP, 
either JadC or TcmM, a homolog of JadC) plus the JadE 
KR and the&&D andju& gene products, proposed to have 
CYC activity. Although only limited information was avail- 
able about the function of the jad PKS genes in angucy- 
cline biosynthesis [l&19], the daunorubicin (dps) PKS 
genes, dpsABCDEFG, which also govern the formation of a 
reduced decaketide and thence an aromatic product with 
three fused aromatic rings (compound 3, Figure l), were 
better understood [20,21]. From the results obtained by co- 
expressing the tcm minimal PKS (specifying the formation 
of a decaketide), act111 KR and g7;s AR0 genes [ 141, which 
gave the major polyketide product SEK43 (Figure 2) we 
predicted that a similar expression construct using the dpsF 
CYC instead of the gris AR0 gene, and the dpsE KR 
instead of the act111 KR gene should also yield SEK43 [14]. 
We therefore decided to use a set of functional expression 
cassettes containing the a&F and dpsE genes, and a corre- 
sponding set of constructs containing the jadD CYC gene 
together with either the dpsE or jadE KR genes, to study 
the design rules for this class of polyketide products. Later, 
our observations on KR specificity, which suggested that 
some KRs are specific for substrates of defined chain 
length, led us to study the properties of polyketide KR 
enzymes in more detail. Previous work on the Act111 KR 
implied that this enzyme could be used for site-specific 
reduction of polyketides of any chain length [5,6,14]. 
Properties of the JadD and DpsF cyclases in hybrid 
polyketide synthases 
We wished to examine the ability of the putative JadD and 
DpsF CYCs to act on either unreduced or C-9 reduced 
octaketide or decaketide chains, with the aim of determin- 
ing whether the proposed JadD CYC would be able to 
direct the formation of an angularly fused three-ring aro- 
matic structure. We therefore constructed a series of expres- 
sion cassettes (Table 1) containing the minimal PKS genes 
from either the tetracenomycin C producer Streptomyces 
glaucescens (tcmJKLM [9]), the daunorubicin producer Strep- 
tomycespeucetius (tcmJ, dpsA, dpsB [20] and tcmM [9]) or the 
actinorhodin producer Streptomyces coelicolor (tcmJ, actI-odl, 
actI-oq2 [ 1’21 and tcmM; Figure 1). The&&C and tcmM ACP 
genes were used interchangeably with the third open 
reading frame (orf) in the act1 gene cluster (a&-o$3) or 
&.sG; several precedents indicated that this should not have 
an adverse effect on the hybrid PKSs [2,6,10,22]. To these 
cassettes, we added the jadD or dpsF CYC genes and the 
dpsE KR gene [ZO], to determine the product(s) resulting 
from the action of the CYC and KR enzymes on the octake- 
tide or decaketide made by the minimal PKS. For expres- 
sion in either Streptomyces &dam 1326 or the down 
promoter mutant S. glaucescens WMH1077 described previ- 
ously [23,24], all gene cassettes were cloned under the 
control of the strong constitutive ermE* promoter [25,26] in 
the Eschen’chia coli-Streptomyces shuttle vector pWHM3 [27]. 
The putative JadD and DpsF CYCs, when expressed 
together with dpsE and either the tcm or the dps minimal 
PKS genes, produced the same polyketides, SEK43 [14] 
and UWM4 (Figure 2; Table 1, entries 7,8,12,13). They 
failed to act on unreduced decaketides provided by the 
same minimal PKSs in the absence of the dp.sE gene 
product, however, yielding SEK1.5 and SEKlSb [5,6] 
(Figure 3; Table 1, entries 6,9,11). Moreover, both CYCs 
also failed to act on octaketides produced by the modified 
act minimal PKS whether or not the &SE KR gene was 
present, so that compounds SEK4 and SEK4b ([5,7]; 
Figure 3) were formed (Table 1, entries l&19,21). The 
failure of both DpsF and JadD to act on octaketides both in 
the presence and absence of the DpsE KR represents 
either a new feature of these CYCs or a minimal chain 
length requirement of DpsE (so far no minimal chain 
length requirement has been demonstrated for AROs, 
CYCs or KRs). The results indicate that, in the contexts 
tested, both the iadD and the dpsF gene products act like 
the ActVII AR0 [ 121 as regiospecific first-ring cyclase/dehy- 
drases of C-9 reduced decaketides (Figures 2,3). In addi- 
tion, they demonstrate that the JadD CYC is not able to 
direct the formation of an angucyclic compound by itself, 
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Figure 2 
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Current concept for the roles of the minimal PKS, KR, AR0 and CYC 
enzymes (colored according to Figure 1) that assemble and process a 
decaketide via the putative intermediates shown. (a) The decaketide is 
assembled from acetate and malonate, reduced and the first ring 
cyclized. Additional cyciization takes place, possibly stepwise in an 
unknown fashion as signified by the ?, to form either the linearly fused 
(for daunorubicin) or angularly fused (for jadomycin B) tetracyclic 
structures. (b) The monocyclic intermediate cyclizes spontaneously in 
two alternative fashions, to form SEK43 or UWM4. 
nor is the DpsF CYC able to form more than one six-mem- 
bered aromatic ring. As DpsF acts as a multiring-forming 
CYC in other contexts (M.G., G.M., E.W.-P., K. Madduri 
and C.R.H., unpublished observations), JadD might do so 
as well (but see below). Moreover, Rajgarhia and Strohl 
[28] have found that DpsF is the only CYC needed in 
cooperation with DpsA, DpsB, DpsE and the DpsG ACP 
to form aklanonic acid, a tricyclic aromatic compound and 
daunorubicin precursor. 
Structure and chemical properties of UWM4 
The polyketide UWM4 is the minor product of several 
decaketide-producing expression constructs involving 
combinations of the DpsF or JadD CYCs with the DpsE or 
JadE KRs (Table 1, entries 7,8,12,13,24). When separated 
by thin layer chromatography (TLC) UWM4 changed from 
colorless to yellow in visible light (and from light-absorbing 
to a pale yellow fluorescence under 310nm UV) which, in 
addition to a slightly higher R, value, enabled UWM4 to be 
distinguished from SEK43. The structure of UWM4 was 
characterized using nuclear magnetic resonance (NMR), 
mass spectroscopy (MS) and formation of the tetra-O- 
methyl derivative. The fast atom bombardment (FAB) 
mass spectrum (m/z: 367.1; negative ions) in combination 
with the NMR experiments led to a molecular mass of 
368.34g/mol and the formula CZoH,,O, for UWM4. The 
similarities between the lH-NMR and 13C-NMR chemical 
shifts of UWM4 and those of SEK43 indicated a close rela- 
tionship (Table 2). Nevertheless, the backbone structure 
of UWM4 was shown to be different from that of SEK43 
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Table 1 
Comoosition of olasmids containing the type II polyketide synthase genes referred to in this paoer. -. . - . . - 
Entry Plasmid*,+ 
1 pWHMl200 tcmK 
2 pWHM1201 tcmK 
3 pWHMl202 tcmK 
4 pWHM862 tcmK 
5 pWHMl203 tcmK 
6 pWHM1204 tcmK 
7 pWHM1205 tcmK 
8 pWHMl206 tcmK 
9 pWHM885 dpsA 
10 pWHM1207 dpsA 
11 pWHMl208 dpsA 
12 pWHMl209 dpsA 
13 pWHM1210 dpsA 
14 pWHMl211 act/-orfl 
15 pWHM1212 act/-off1 
16 pWHM1213 act/-off1 
17 pWHM1214 act/-off1 
18 pWHMl215 act/-off1 
19 pWHMl216 actl-orf 1 
20 pWHM1217 actl-orfl 
21 pWHM1218 actl-orfl 
22 pWHM1219 actl-off1 
23 pWHMl220** jadA 
24 pWHMl221** jadA 
KS, KS,* 
tcmL 
tcmL 
tcmL 
tcmL 
tcmL 
tcmL 
tcmL 
tcmL 
dpsi3 
dpsB 
dpsB 
dpsB 
dpsB 
actl-orf2 
actl-orf2 
actl-orf2 
actl-orf2 
actl-orf2 
actl-orf2 
actl-orf2 
actl-off2 
actl-off2 
jadB 
jadB 
ACP 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
tcmM 
jadC 
KR 
-# 
dpsf 
jadf 
dpsf 
dpsE 
dpsf 
dpsE 
dpsf 
dpsE 
dpsf 
actlll 
jadf 
dpsE 
act/II 
dpsf 
act/II 
jadf 
CYC 
tcmN 
tcmN 
jadD 
jadD 
dpsF 
- 
jadD 
jadD 
dpsF 
- 
jadD 
jadD 
jadD 
dpsF 
dpsF 
tcmN 
jadD 
Metabolites 
produced5 
TcmF2, SEK15, SEKI 5b 
RM20b,c 
RM20b,c 
TcmF2 _’ 
TcmF2, RMPOb 
SEKl5, SEKl5b 
SEK43, UWM4, SEK15 
SEK43, UWM4, SEK15 
SEK15, SEK15b 
RMPOb,c 
SEK15, SEKl5b 
SEK43, UWM4 
SEK43, UWM4 
SEK4, SEK4b 
SEK4, SEK4b 
Mutactin, dehydromutactin 
Mutactin, dehydromutactin 
SEK4, SEK4b 
SEK4, SEK4b 
SEK34 
SEK4, SEK4b 
SEK34 
TcmF2 
SEK43, UWM4 
Referencen 
[91 
[91 
181 
[91 
[El 
*The tcmJ gene is present in all of the plasmids unless indicated otherwise. +The first three genes were cloned in the order shown in the table, 
preceded by ermE*::tcmk the order of the KR and CYC genes varied, although the KR gene was most often last. *Synonymous with a CLF gene. 
§The same metabolites were produced in S. lividans and S. glaucescens. nlf no reference is given, the data referred to are from this work. 
#Indicates the lack of such a gene. **tcmJ replaced with jadl. 
(Figure 2) by recording heteronuclear multiple-bond 
correlation (HMBC) and heteronuclear multiple-quantum 
coherence (HMQC) spectra of their tetra-O-methyl deriva- 
tives. These data also suggested that, although ring A had 
previously been assumed to form a pyrone structure in this 
kind of compound [6], in fact a S-lactone is preferred. 
The long-range correlations in the HMBC spectrum 
(Figure 4a), the X-ray crystal structure (Figure 4b) and the 
13C-NMR data of UWM4 and SEK43 proved that the 
3-methoxy and not the 1-methoxy isomer was formed upon 
methylation, from which it was possible to assign the 
chemical shifts of C-3 to an enol group and C-l to a 
lactone. The conversion of UWM4 to a yellow compound 
under acidic conditions is likely to have involved an aldol 
condensation between the methylene group at C-6 and the 
keto group at C-19 (Figure 4c) because the resulting 
tetracyclic product should be a new chromophore. 
Comparison of the structures of UWM4 and SEK43 sug- 
gests that DpsF or JadD catalyzed cyclization of the first 
ring between C-7 and C-12 in both compounds, but that 
folding and cyclization of the two other rings was some- 
what random and directed more by kinetic or thermody- 
namic factors than by enzymatic catalysis. The ratio of 
SEK43 to UWM4 in the isolated material (17:l) suggests 
that the aldol condensation involving the terminal carbonyl 
group at C-19 and the C-14 methylene of the decaketide 
intermediate is favored over that involving the C-18 meth- 
ylene and C-13 carbonyl. This outcome is consistent with 
earlier work of Harris and Harris [29] on the solution 
chemistry of poly-carbonyl compounds and observations 
by Khosla and coworkers [5,7] on the cyclization of an 
octaketide to SEK4 and SEK4b. 
Properties of the DpsE ketoreductase compared to the 
Actlll and JadE ketoreductases 
To investigate further whether the activities of the JadD 
CYC, DpsF CYC or DpsE KR require polyketides of a 
certain chain length, the dpsE gene was replaced by the 
actlll gene in all relevant constructs involving the modified 
act minimal PKS genes. The compounds produced from 
the expression of these new cassettes were analysed as 
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Figure 3 
.ocLo .oL3o .o,, .a,* 
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RM20b,c 
Structures of some of the octaketide and 
decaketide metabolites discussed in the text. 
The position corresponding to the C-9 
carbonyl of the polyketide precursor, which 
may or may not have undergone reduction by 
a KR, is marked with a red dot in each 
structure. The decaketides RMPOb and 
RM20c are diastereomers. 
before. All of the new constructs produced either mutactin 
[30], dehydromutactin [6] or SEK34 [13] (Figures 35; 
Table 1, entries 16,17,20,21), indicating that DpsE requires 
a polyketide chain length of more than 16 carbons to be 
able to catalyze carbonyl reduction, whereas both the JadD 
and the DpsF CYCs work properly with reduced octake- 
tides. We then made two additional expression constructs 
by adding the jadE KR gene to the tcm and modified act 
minimal PKS genes, respectively. As expected, the combi- 
nation of the tcm minimal PKS and JadE KR produced the 
decaketides RMZOb and RMZOc (Figure 3; Table 1, 
entry 3); the JadE KR was also able to reduce the octake- 
tides produced by the modified act minimal PKS, yielding 
mutactin and dehydromutactin (Table 1, entry 17). These 
results reveal an unexpected feature of the DpsE KR and 
suggest that KR subunits in general might exhibit different 
specificities for different sized polyketide intermediates 
unless there is some other reason for the apparent lack of 
DpsE function, such as critical protein-protein interactions. 
Cloning artifacts are unlikely, since the same restriction 
fragment was used in all constructs. The specificity of KR 
enzymes could be context dependent; if so, this may 
explain why the dpsE homolog in Streptomyces galilaeus 
apparently can act on the octaketide produced by the intro- 
duction of the ad-od2 and actl-oq2 PKS genes into this 
organism [31] but cannot act on the substrate produced 
when these genes are introduced into Stwptomyces sp. strain 
C.5 (W.R. Strohl, personal communication). 
The DpsE ketoreductase and TcmN cyclase: competition for 
the nascent decaketide chain 
McDaniel et al. [lo] had reported earlier that a combina- 
tion of the tcm minimal PKS, the Act111 KR and the 
TcmN CYC produced the C-9 reduced decaketides 
RMZOb and RMZOc. They concluded that ketoreduction 
must occur prior to cyclization during the biosynthesis of 
reduced polyketides, as suggested earlier by Bartel et al. 
[31], and that TcmN is unable to act on C-9 reduced 
polyketides. In view of the order of events in the biosyn- 
thesis of reduced and unreduced decaketides, it would 
seem that the nascent decaketide chain produced by the 
minimal PKS could serve as substrate for both a KR and 
the TcmN CYC. The expected outcome would be a 
mixture of tetracenomycin [32] and RMZOb and RMZOc as 
a result of the competition between the two enzymes for 
the same substrate. We therefore constructed an expres- 
sion cassette containing the tcmJKLM PKS genes, the 
tcmN CYC gene and the dpsE KR gene. The production of 
secondary metabolites during cultivation of S. livhfans 
1326 transformants in liquid medium was followed using 
TLC and established that tetracenomycin F2 as well as 
RM20b and RM20c were formed initially (Table 1, 
entry 5), but the amount of the unstable tetracenomycin 
F2 diminished to the point of undetectability after one 
week. This explains the observations of McDaniel et al. 
[lo] and clearly demonstrates that the DpsE KR and 
TcmN CYC, although competing for the same substrate, 
perform mutually exclusive reactions. 
The jad minimal polyketide synthase does not make 
angucyclic polyketides in artificial polyketide synthase 
systems 
The above results reveal that the JadD CYC itself cannot 
influence the heterologous sets of PKS genes studied to 
form an angucyclic polyketide structure. A second gene 
product from thejadgene cluster, JadI, is predicted to be a 
CYC enzyme on the basis of its close sequence similarity to 
TcmI, the CYC that converts the tricyclic tetracenomycin 
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Table 2 
‘H and 13C NMR data for SEK43 and UWM4, tetra-0-methyl-SEK43 and tetra-0-methyl-UWM4. 
SEK43 UWM4 Tetra-0-methylSEK43 Tetra-0-methylUWM4 
Carbon* '%+8 l H* 6 (ppm) ‘0 6 ‘l-i* 6 (ppm) ‘W 6 H* 6 kvm) ‘XY 6 i I+ 6 (ppm) 
(ppm) (m, J HHlH~l, area) (tm) (m, J HHIH~l, area) (w-d (m, J &lzl, area) (ppm) (m, J ,,[Hzl,area) 
1 168.1 
2 89.0 
3 173.3 
4 103.4 
5 165.0 
6 38.1 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
3-CH, 
ll-CH, 
15-CH, 
17CH, 
133.4 
123.2 
123.2 
116.1 
155.2 
132.3 
202.2 
116.5 
168.3 
102.1 
165.7 
113.3 
145.3 
22.3 
5.20 (d, 2.0, 1H) 
5.72 (d, 2.0, 1H) 
3.66 (s, 2H) 
6.91 (d, 8.0, 1H) 
7.29 (t, 8.0, 1H) 
6.94 (d, 8.0, 1H) 
6.19 (d, 3.0, 1H) 
6.25 (d, 3.0, 1H) 
1.86 (s,3H) 
166.5 
89.6 
171.7 
103.5 
164.1 
38.1 
135.8 
122.5 
121.7 
115.4 
155.2 
130.8 
142.6 
113.0 
165.0 
102.3 
166.5 
115.4 
202.9 
29** 
5.19 (s, 1H) 
5.72 (s, 1H) 
3.63 (d, 15.5, 1H) 
3.55 (d, 15.5, 1H) 
6.95 (d, 8.0, 1H) 
7.26 (t, 8.0, 1H) 
6.93 (d, 8.0, 1 H) 
6.26 (d, 2.6, 1H) 
6.33 (d, 2.6, 1H) 
1.87 (q3H) 
161.0 
87.9 
172.0 
101.5 
164.2 
37.4 
135.2 
123.5 
130.7 
111.5 
158.3 
134.6 
198.8 
141.6 
162.9 
96.7 
165.0 
109.3 
124.8 
20.9 
56.5 
56.0 
55.7 
56.3 
5.39 (d, 2.2, 1H) 
5.69 (d, 2.2, 1H) 
3.78 (s, 2H) 
6.94 (d, 8.0, 1H) 
7.33 (t, 8.0, 1H) 
6.94 (d, 8.0, 1H) 
6.33 (d, 2.2, 1H) 
6.45 (d, 2.2, 1H) 
2.37 (s,3H) 
3.82 (s,3H) 
3.60 (s,3H) 
3.48 (s, 3H) 
3.81 (s,3H) 
164.4 
87.7 
171.7 
101.2 
164.3 
37.9 
135.6 
122.6 
129.1 
109.7 
156.5 
129.8 
136.6 
107.6 
158.2 
98.3 
161.5 
124.9 
202.6 
30.1 
56.1 
55.9 
56.3 
55.9 
5.3** (1H) 
5.55 (d, 2.0, 1H) 
3.51 (d, 16.0, 1H) 
3.61 (d, 16.0, 1H) 
6.91 (d, 7.7, 1H) 
7.30 (t, 7.7, 1H) 
6.86 (d, 7.7, 1H) 
6.23 (d, 2.2, 1H) 
6.50 (d, 2.2, 1H) 
2.23 (s, 3H) 
3.74 (s,3H) 
3.73 (s, 3H) 
3.86 (s, 3H) 
3.70 (s,3H) 
*Carbons are labeled according to their number in the polyketide backbone.+(75.5 MHz, methanol-d,);*(300 MHz, acetone-d,);§(75.5 MHz, 
acetone-d,); n(75.5 MHz, CD,CI,);#(300 MHz, CD&I,).** Indicates overlapping with solvent. 
F2 to the tetracyclic tetracenomycin Fl (K. Yang, L. Han 
and L.C.V., unpublished observations.) We therefore inves- 
tigated whether the jad minimal PKS or the putative JadI 
CYC could instead perform this transformation. To this end 
we constructed two expression cassettes both containing 
the j,d minimal PKS genes GadA, jadB and jadC or jadA, 
jadB and tcmM) and the jadr gene together with either the 
tcmN gene or the jadE KR and jadD CYC genes. If either 
one of the constructs produced an angucycline, we would 
then have had to determine the functions of JadI and the 
jad minimal PKS separately. The expression cassette com- 
prising the jaa7ABCED genes again produced SEK43 and 
UWM4, however, in the same ratio seen with comparable 
but heterologous cassettes containing the jadD or dpsF 
genes, whereas the jadIAB plus tcmMN genes produced 
tetracenomycin FZ (Table 1, entries 23,24). Because the 
judIABCED genes, which were cloned in the native order 
(Figure l), did not produce an angular polyketide, the 
jadABC or j&‘ZABC genes alone would also have been 
unable to produce such a backbone. These results indicate 
that the jad minimal PKS does not determine the formation 
of an angular polyketide backbone, that the intermediate 
with a single aromatic ring produced by JadABCED is not a 
substrate for the putative JadI CYC (explaining the forma- 
tion of SEK43 and UWM4), and that tetracenomycin F2 is 
not a substrate for JadI either, even though we believe that 
JadI is a fourth ring CYC. 
The data presented here, together with the results obtained 
from expression cassettes containing the a&V second/third 
ring CYC gene [2,13], imply that another CYC besides JadI 
might be required to form the second and third aromatic 
rings during the biosynthesis of jadomycin and other 
angucyclines. Many of the clusters of PKS genes that 
govern the biosynthesis of polycyclic reduced aromatic 
polyketides, such as the daunorubicin [20,21] or the 
urdamycin [33] (A. Bechthold and J. Rohr, personal com- 
munication) clusters, however, lack an homolog of a&V or 
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Figure 4 
(a) 
(Cl * -H2o F $$ 
Properties of UWM4 and SEK43. (a) The 
long-range correlations observed in the 
HMBC spectrum of 3,ll ,I 5,17-tetra-O- 
methylUWM4. (b) The structure of 
3,i 1 ,15,17-tetra-0-methyl-SEK43 determined 
by X-ray crystallography. (c) Postulated 
mechanism for the reaction of UWM4 with 
acid. 
other genes that can be deduced to produce such CYCs, 
although dpsH is one candidate (Figure 1). Furthermore, in 
S. lividam expression of the dps PKS genes in their natural 
order (+-L&G and tdpsFdpsEl/a’nrGdpsAdpsB+, where the 
arrows indicate the direction of transcription), under control 
of the native promoters, leads to the production of 
aklanonic acid (M.G., G.M., E.W.-P., K. Madduri and 
C.R.H., unpublished observations) [28], whereas the same 
genes, when expressed from an artificial operon (dn&ps- 
AdpsBdpsEdpsFdpsG+) under control of the emE” pro- 
moter, produce mainly SEK43 and only traces of aklanonic 
acid (M.G., G.M., E.W.-P., K. Madduri and C.R.H., unpub- 
lished observations). These observations reveal that PKS 
subunits, which function normally in the native context, can 
function aberrantly when they are produced in viva from an 
artificially constructed gene cassette. It is an attractive pos- 
sibility that this difference in function may be due to a 
change in the ratio of PKS subunits. It seems likely that the 
j,d PKS genes studied here can form an angucycline-pro- 
ducing PKS complex if expressed in the native setting but 
cannot do so in the context of currently available hybrid or 
otherwise artificial PKS expression systems. This belief has 
RM80b TW97 
Figure 5 
Representative polyketides produced by type 
II PK.%. (a) The octaketide or decaketide is 
reduced at C-9 by the Actlll or JadE KR and 
the first (central) ring is formed by the ActVll 
ARO, or DpsF or JadD CYC enzyme. The 
octaketide framework is colored pink. (b) The 
octaketide, decaketide or dodecaketide is not 
reduced before the bicyclic ring system is 
formed by the TcmN CYC enzyme for PK8 
[15] and RM80b [I 01 and the WhiE CYC for 
TW97 [40] (C. Khosla, personal 
communication). The octaketide framework is 
colored red. 
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an important corollary: heterologous sets of type II PKS 
genes may have functional limitations that have previously 
been unappreciated in the quest for the production of 
hybrid antibiotics by recombinant bacteria [14]. 
Significance 
Combinatorial expression of genes that encode the sub- 
units of Streptomyces polyketide synthase (PKS) com- 
plexes has been proven to be supremely successful in 
probing the function of these enzymes. The resulting 
increase in the understanding of the inner workings of 
a type II PKS and, consequently, the improved pre- 
dictability of metabolite production patterns led to 
the establishment of design rules for the engineered 
biosynthesis of novel polyketides. These design rules 
are also a direct consequence of an emerging set of 
basic, re-occurring compound structures - produced by 
hybrid PKS systems -that vary in their peripheral 
functionality only because of differences in chain length 
of the nascent polyketides (Figure 5). By incorporating 
secondary polyketide cyclases into hybrid PKS expres- 
sion systems a more diverse range of polyketide back- 
bone will be produced which can be still further 
modified at later stages. 
Here we investigated whether it was possible to achieve 
an additional degree of polyketide structural diversity 
through the early introduction of a kink into the nascent 
polyketide chain. We attempted to do this by expressing 
PKS genes from an angucycline producer together with 
PKS genes from other systems that have been better 
defined. The products we expected were not formed, 
however. Instead, we found that the biosynthesis of 
angular aromatic polyketides superficially seems to 
adhere to the same rules established for the production of 
linear aromatic decaketides, in which the initial polyke- 
tide undergoes one carbonyl reduction step prior to ring 
formation. Although it can be inferred from this observa- 
tion that a subsequent cyclization step (and perhaps an 
extra enzyme) is responsible for the introduction of the 
kink, our results favor the notion that certain PKS com- 
plexes function abnormally when formed from artificial 
gene sets, resulting in single rather than multiple enzy- 
matic cyclizations of the nascent polyketide. In the 
course of this work we also established a specific chain 
length requirement for the DpsE polyketide ketoreduc- 
tase that distinguishes it from Act111 and JadE, the other 
ketoreductase enzymes tested to date. 
Materials and methods 
Bacterial strains and plasmids 
The S. glaucescens type strains [24], S. lividans 1326 [341, the bac- 
teriophages M13mpl8, Ml 3mpl9 [35] and the plasmid pWHM3 [27] 
are described elsewhere. The ermE* promoter was isolated as 
reported earlier [24,25]. The vectors pGEM3,5,7,9,1 lZf(+) were pur- 
chased from Promega (Madison, WI, USA), pUC19 from New England 
Biolabs (Beverly, MA, USA) and pBluescript SK+ from Stratagene 
(La Jolla, CA, USA). The f. co/i strains used were DH~LY, TGI and 
DHl 0. The plasmids used in this study are described in Table 1. 
Culture conditions, chemicals and other materials 
R2YENG liquid medium (pH 6) and agar plates 1361 were used for pro- 
duction of secondary metabolites. S. glaucescens spores were isolated 
after growth on HT medium [24] and S. lividans spores were isolated 
after growth on R2YE agar 1361. S. glaucescens and S. lividans were 
grown in CRM medium [37] for preparation of protoplasts, and proto- 
plasts were regenerated on RPYE agar. Thiostrepton concentrations of 
50pglml on solid media and 10 pg/ml in liquid media were used for 
selective growth of all Streptomyces sp. Recombinant E. co/i DH5a 
and DHlO were grown in LB or TB 1381 medium containing 1 OOpg of 
ampicillin per ml and M13mp18, M13mp19 were propagated in TGl 
cells grown in 2 x YT medium [38]. Thiostrepton was obtained from Sal 
Lucania at the Squibb Institute for Medical Research (Princeton, NJ, 
USA) and all chemicals used in this study were analytical grade. Silica 
gel (Kieselgel 60; 0.040-0.063 pm) and TLC plates (silica gel 60 
F& were obtained from E. Merck (Darmstadt, Germany). Restriction 
enzymes, DNA ligase and other molecular biology materials were 
purchased from standard commercial sources. 
PCR cloning of the jadD cyclase and jadE ketoreductase genes 
The jadD gene was amplified using plasmid pJV69A 1181, linearized with 
EcoRI, as template and the following oligonucleotides, synthesized by 
the University of Wisconsin Biotechnology Center, as PCR primers: 
JadDf: 5’ GCG GCG GAA TTC GAG CTC GAG GAG TTT CAC GAT 
GAC GAC CCG TGA GG 3’ and JadDr: 5’CCG CGC ATG CAT TCA 
TCA GCG CTT GCC CTC GGC GTA GGC3’. For the amplification of 
the jadE gene, a subclone of pJV69A was precut with EcoRl and used 
as template together with the PCR primers JadEf: 5’ACG TCA TCT 
AGA GAA GAG ACG ACA CCG CAT GTC CCA GC3’ and JadEr: 
5’ACG TCA AAG Cl-r TCA GAA GTT GCC CAG GCC GCC GC3 
in the PCR assay. The following conditions were used to perform the 
PCR reactions: 100 ~1 of reaction mix contained 100 ng of precut tem- 
plate DNA, 0.5~g of each of the custom made PCR primers, 2.5mM 
MgCI,, 1OObg BSA, 0.06mM dCTP+dGTP, 0.04mM dATP+dTTP 
and 10 U of Taq- polymerase (Fisher Scientific, Pittsburgh, PA, USA) in 
lx assay buffer. The reaction conditions were chosen as follows: an 
initial denaturation for 5 min at 100°C was followed by 3min at 71°C 
during which time the dNTPs and 5U Taq-polymerase were added. 
Then 24 cycles of 1.5 min denaturation at 97°C and 3 min extension at 
70°C during which an additional 5 U of Taq-polymerase was added. The 
program was concluded by a final denaturation and a 10 min extension 
cycle after which the reaction mix was cooled down to 4°C. The PCR 
mix was purified from contaminating oil and free dNTPs using an Ultra- 
free@-MC filter unit (Millipore Corporation, Bedford, MA, USA) following 
the manufacturer’s instructions. The amplified jadD and jadE genes 
were used for further cloning of expression cassettes as EcoRI-&I and 
Xbal-Hindlll fragments, respectively. 
DNA sequence analysis 
The amplified jadD and jadE genes were sequenced by the chain termi- 
nation method with Sequenase 2.0 (United States Biochemical, Cleve- 
land, OH, USA) using [ol-35S]dCTP following the manufacturer’s 
instructions and 7-deaza-dGTP to reduce the number of sequencing arti- 
facts. The sequencing samples were run on 60cm wedged 8M urea- 
10% formamide-6% polyactylamide gels. DNA and protein sequence 
analysis was done with the Genetics Computer Group software package 
version 8.1 [39]. 
While sequence analysis did confirm the sequence of the amplified jadE 
gene to be identical with the published sequence data [181, several dif- 
ferences were detected for thejadD PCR product. Sequence analysis of 
the template DNA used (pJV69A) and subsequently of a piece of 
genomic DNA isolated from S. venezuelae ISP5230 [18], using the jadD 
PCR product as hybridization probe, revealed the following errors in the 
4864 bp jadD sequence published in [18]: position 4119: 5’GGGCG- 
GCA3’ instead of 5’GGCGA3’; position 4155: 5’GTCCCG 3’ instead 
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of 5’GTCCG 3’; position 4166: 5-CCTG3’ instead of 5’CCTTG3’ and 
position 4216: 5’TGGATC3’ instead of S’TGGGTCS’. 
Metabolite production and purification 
DNA fragments containing the hybrid PKS expression cassettes under 
control of the ermE* promoter were cloned into pWHM3 to give the 
plasmids described in Table 1 and were introduced by transformation 
into protoplasts of S. lividarts and S. glaucescens strains. Thiostrepton 
resistant transformants were selected by overlaying the plates with 
thiostrepton to give a final concentration of 20ug/ml. Transformants 
were initially grown in 5ml R2YENG medium plus thiostrepton for 
4days and subsequently transferred to 20-50ml cultures and grown 
for another 40 h. A portion of each culture was extracted with ethyl 
acetate and the extract was analyzed by TLC on silica gel (E. Merck, 
Darmstadt, Germany) in chloroform:methanol:acetic acid (40:10:1.25) 
to detect the production of secondary metabolites by illuminating the 
solvent-damp plates with UV light (31 Onm). For large scale production 
of metabolites 3 I of RPYENG (50ml portions in 250 ml baffled 
Erlmeyer flasks) were inoculated with 5 x 5 mm slices of a well sporu- 
lated culture on HT or RPYE agar (+ thiostrepton). These were incu- 
bated at 30°C with shaking (350 revlmin) for 3 days. The culture broth 
was then mixed with 14gll KH,PO, and the mycelia were removed by 
filtration. The filtrate was divided into 4 portions and each portion was 
then extracted 5 times with a total of 500 ml ethyl acetate. The mycelia 
was extracted 5 times with a total of 250ml acetone. The combined 
organic layers were evaporated to dryness in vacua, redissolved in 5 ml 
of chloroform:methanol (85:15) and subjected to chromatography on a 
silica gel column (35x3cm) using the same solvent mixture for separa- 
tion. Fractions containing SEK43 and UWM4 (analyzed by TLC: 
&=0.72 and 0.74 in chloroform:methanol:acetic acid [80:20:0.25]) 
were evaporated as before and further purified on a silica gel column 
(l5x2cm, chloroform:methanol i9:1]) to give 500mg SEK43 and 
30mg UWM4 in a ratio of 17:l. RMPOb, RMPOc, SEK4, SEK4b, 
mutactin, dehydromutaction, and SEK34 were identified by comparison 
of their chromatographic and spectral properties with known standards. 
Qeriva’tization of UWM4 and SEK43 
In a‘1 0 ml round flask, 2.9 mg UWM4 (0.008 mmol) was dissolved in 
5 ml acetone, 1.59 K&O, and 1 ml methyl iodide. After 10 h the 
reaction was quenched by adding 5 ml of water,,stirring for 3 h until 
homogeneous and extracted 3 times with 10 ml of ethyl acetate. The 
combined organic layers were washed with 5ml of saturated aq. 
NaHCO, and 5 ml water and the organic fraction was dried in vacua. 
The remaining residue was dissolved in a mixture of cyclohexane:ethyl 
acetate (6:4) and chromatographed in the same solvent system on 
log of silica gel to give 3.6mg of crude product (Rf=0.28). This 
product was purified by high performance liquid chromatography 
(HPLC) using a solvent system of acetonitrile:water (1 :l) on a 
Waters RCM 25 x 10 mm RP-C,, preparative column to yield 2.0 mg 
(0.005 mmol, 63%) of 3,i 1 ,15,17-tetra-0-methylUWM4. The same 
procedure was done using 27.0 mg (0.08 mmol) SEK43 with doubled 
amounts of reagents and solvents to give 1’6.5 mg (0.04 mmol, 50%) 
3,i 1 ,15,17-tetra-0-methylSEK43 @=0.20 in cyclohexane:ethyl 
acetate [6:4]). Crystals of the latter product were obtained by dis- 
solving 16.5 mg in 1 ml ethyl acetate and keeping the mixture uncov- 
ered in a 1 Oml flask at room temperature to evaporate the 
solvent slowly. 
MS, NMR and X-ray analysis 
Electron ionization (El)-MS was carried out on a Kratos MS-EORFA 
spectrometer and FAB-MS on a Finnigan MAT 8230 (matrix:o:nitro- 
benzylalcohol). The X-ray analysis was done using a Siemens Analyti- 
cal X-ray Instrument and NMR spectra were recorded on a Bruker 
AM3000 spectrometer with exception of the HMBC and HMQC 
spectra, which were recorded on a Bruker DMX500. For recording 
NMR spectra, the compounds were dissolved in CDsOD (Aldrich, 
99.5 atom % D), acetone-d, (Aldrich, 99.5 atom % D), CD,CI, (Merck 
Sharp & Dohme, 99 atom O/o D) or, for direct comparison with the 
literature, DMSO-d, (Aldrich, 100.00/o D). 
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